anthralin has been researched along with Dermatitis, Contact in 30 studies
Anthralin: An anthracene derivative that disrupts MITOCHONDRIA function and structure and is used for the treatment of DERMATOSES, especially PSORIASIS. It may cause FOLLICULITIS.
anthralin : An anthracene compound derived by the substitution of -OH groups for hydrogen at C-1 and C-8, and with an oxo group at C-9.
Dermatitis, Contact: A type of acute or chronic skin reaction in which sensitivity is manifested by reactivity to materials or substances coming in contact with the skin. It may involve allergic or non-allergic mechanisms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A PRISMA-compliant systematic review of seven electronic databases was searched by the terms "alopecia areata," "pediatric," "topical immunotherapy," "Anthralin," and "light therapy" from inception until March 2021." | 9.22 | A systematic review on the treatment of pediatric severe alopecia areata by topical immunotherapy or Anthralin (contact sensitization) or low-level light/laser therapy (LLLT): focus on efficacy, safety, treatment duration, recurrence, and follow-up based ( Behrangi, E; Dodangeh, M; Ghassemi, M; Goodarzi, A; Najar Nobari, N; Roohaninasab, M; Sadeghzadeh-Bazargan, A; Seirafianpour, F, 2022) |
| "A PRISMA-compliant systematic review of seven electronic databases was searched by the terms "alopecia areata," "pediatric," "topical immunotherapy," "Anthralin," and "light therapy" from inception until March 2021." | 5.22 | A systematic review on the treatment of pediatric severe alopecia areata by topical immunotherapy or Anthralin (contact sensitization) or low-level light/laser therapy (LLLT): focus on efficacy, safety, treatment duration, recurrence, and follow-up based ( Behrangi, E; Dodangeh, M; Ghassemi, M; Goodarzi, A; Najar Nobari, N; Roohaninasab, M; Sadeghzadeh-Bazargan, A; Seirafianpour, F, 2022) |
| "The inflammatory dose-response to topical anthralin and whole skin aryl hydrocarbon hydroxylase (AHH) activity were measured before and 24 h after application of a coal tar solution to the uninvolved skin of patients with psoriasis." | 3.67 | Effect of coal tar on cutaneous aryl hydrocarbon hydroxylase induction and anthralin irritancy. ( Finnen, MJ; Lawrence, CM; Shuster, S, 1984) |
| "The effect of topical clobetasol propionate and a 1% topical indomethacin gel which could inhibit UV erythema was measured on anthralin inflammation by change in skin-fold thickness and erythema." | 3.67 | Mechanism of anthralin inflammation. I. Dissociation of response to clobetasol and indomethacin. ( Lawrence, CM; Shuster, S, 1985) |
| "Cell mediated immune reactivity was studied in eighty-five psoriasis patients and twenty-five healthy controls by an improved (quantitative) method for measuring contact hypersensitivity to 2,4 dinitrochlorobenzene (DNCB)." | 3.66 | Impaired contact hypersensitivity in untreated psoriasis and the effects of photochemotherapy and dithranol/UV-B. ( Friedmann, PS; Moss, C; Shuster, S, 1981) |
| "The induction of contact hypersensitivity was inhibited only by PUVA, and not by the other treatments." | 1.28 | The influence of topical dermatological treatment modalities on epidermal Langerhans cells and contact sensitization in mice. ( Gruner, S; Sönnichsen, N; Strunk, D; Zwirner, A, 1992) |
| "Anthralin and UVB were then applied to the gel-treated skin and the anthralin- and UVB-induced erythema and oedema were measured at 2, 6, 24 and 48 h using Harpenden callipers and a reflectance erythrometer." | 1.28 | The effect of indomethacin on anthralin inflammation. ( Lawrence, C; Ramsay, B; Rice, N, 1992) |
| "8 of these 13 reacted with blister formation after exposure to 0." | 1.27 | Irritant potential of dithranol. ( Haustein, UF; Lohrisch, I, 1986) |
| "Anthralin inflammation was increased after 1% hydrocortisone application and decreased by 0." | 1.27 | Mechanism of anthralin inflammation. 2. Effect of pretreatment with glucocorticoids, anthralin and removal of stratum corneum. ( Lawrence, CM; Shuster, S, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 20 (66.67) | 18.7374 |
| 1990's | 9 (30.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (3.33) | 2.80 |
| Authors | Studies |
|---|---|
| Behrangi, E | 1 |
| Roohaninasab, M | 1 |
| Sadeghzadeh-Bazargan, A | 1 |
| Najar Nobari, N | 1 |
| Ghassemi, M | 1 |
| Seirafianpour, F | 1 |
| Goodarzi, A | 1 |
| Dodangeh, M | 1 |
| Kanerva, L | 2 |
| Ranki, A | 2 |
| Lauharanta, J | 2 |
| de Groot, AC | 3 |
| Nater, JP | 3 |
| Bleumink, E | 1 |
| de Jong, MC | 2 |
| Kersey, P | 1 |
| Chapman, P | 1 |
| Rogers, S | 1 |
| Rawlins, M | 1 |
| Shuster, S | 8 |
| Lawlor, F | 1 |
| Hindson, C | 1 |
| Gonçalo, S | 1 |
| Sousa, I | 1 |
| Moreno, A | 1 |
| Lawrence, CM | 5 |
| Finnen, MJ | 1 |
| Savin, JA | 1 |
| Mustakallio, K | 1 |
| Moss, C | 1 |
| Friedmann, PS | 1 |
| Willis, CM | 1 |
| Stephens, CJ | 1 |
| Wilkinson, JD | 1 |
| Gruner, S | 1 |
| Zwirner, A | 1 |
| Strunk, D | 1 |
| Sönnichsen, N | 1 |
| Ramsay, B | 1 |
| Rice, N | 1 |
| Lawrence, C | 1 |
| Viluksela, M | 2 |
| Kosma, VM | 1 |
| Kodari, E | 1 |
| Pavone, A | 1 |
| Reiners, JJ | 1 |
| McLelland, J | 1 |
| Matthews, JN | 1 |
| Haasio, K | 1 |
| Männistö, PT | 1 |
| Eter, J | 1 |
| Schulze, HJ | 1 |
| Mahrle, G | 1 |
| Kemény, L | 1 |
| Csató, M | 1 |
| Braquet, P | 1 |
| Dobozy, A | 1 |
| Hamami, I | 1 |
| Marks, R | 1 |
| Gawkrodger, DJ | 2 |
| Carr, MM | 2 |
| McVittie, E | 2 |
| Guy, K | 1 |
| Hunter, JA | 2 |
| Ross, JA | 1 |
| Hensby, CN | 1 |
| Shroot, B | 1 |
| Chatelus, A | 1 |
| Cavey, D | 1 |
| Allec, J | 1 |
| Maignan, J | 1 |
| Howel, D | 1 |
| Haustein, UF | 1 |
| Lohrisch, I | 1 |
1 review available for anthralin and Dermatitis, Contact
| Article | Year |
|---|---|
A systematic review on the treatment of pediatric severe alopecia areata by topical immunotherapy or Anthralin (contact sensitization) or low-level light/laser therapy (LLLT): focus on efficacy, safety, treatment duration, recurrence, and follow-up based
Topics: Administration, Topical; Alopecia Areata; Anthralin; Child; Dermatitis, Contact; Duration of Therapy | 2022 |
1 trial available for anthralin and Dermatitis, Contact
| Article | Year |
|---|---|
Keratinocyte expression of MHC class II antigens in allergic sensitization and challenge reactions and in irritant contact dermatitis.
Topics: Anthralin; Dermatitis, Contact; Dinitrochlorobenzene; Female; Histocompatibility Antigens Class II; | 1987 |
28 other studies available for anthralin and Dermatitis, Contact
| Article | Year |
|---|---|
Lymphocytes and Langerhans cells in patch tests. An immunohistochemical and electron microscopic study.
Topics: Anthralin; Antibodies, Monoclonal; Dermatitis, Contact; Humans; Immunoenzyme Techniques; Irritants; | 1984 |
Does DNCB therapy potentiate epicutaneous sensitization to non-related contact allergens?
Topics: Adolescent; Adult; Alopecia Areata; Anthralin; Child; Dermatitis, Contact; Dinitrochlorobenzene; Dru | 1981 |
The inflammatory response to anthralin and its relation to aryl hydrocarbon hydroxylase.
Topics: Anthracenes; Anthralin; Aryl Hydrocarbon Hydroxylases; Dermatitis, Contact; Dose-Response Relationsh | 1981 |
Allergy to dithranol.
Topics: Anthracenes; Anthralin; Dermatitis, Contact; Drug Eruptions; Female; Humans; Patch Tests; Psoriasis | 1982 |
Contact dermatitis to coal tar.
Topics: Adolescent; Adult; Anthracenes; Anthralin; Coal Tar; Dermatitis, Contact; Female; Humans; Patch Test | 1984 |
Effect of coal tar on cutaneous aryl hydrocarbon hydroxylase induction and anthralin irritancy.
Topics: Adult; Anthracenes; Anthralin; Aryl Hydrocarbon Hydroxylases; Coal Tar; Dermatitis, Contact; Dose-Re | 1984 |
Hair-raising notions and lotions.
Topics: Alopecia; Anthralin; Dermatitis, Contact; Dinitrochlorobenzene; Humans | 1982 |
Langerhans cell--mononuclear cell contacts are not specific for allergy in patch tests.
Topics: Allergens; Anthralin; Cell Communication; Chromium; Dermatitis, Contact; Fatty Acids; Humans; Irrita | 1983 |
Contact allergy to dithranol.
Topics: Adult; Anthracenes; Anthralin; Dermatitis, Contact; Female; Humans; Patch Tests; Psoriasis; Warts | 1981 |
Impaired contact hypersensitivity in untreated psoriasis and the effects of photochemotherapy and dithranol/UV-B.
Topics: Adult; Aged; Anthralin; Dermatitis, Contact; Dinitrochlorobenzene; Dose-Response Relationship, Immun | 1981 |
[Dinitrochlorobenzene treatment of alopecia areata].
Topics: Adolescent; Adult; Alopecia Areata; Anthracenes; Anthralin; Child; Dermatitis, Contact; Dinitrochlor | 1980 |
Differential patterns of epidermal leukocyte infiltration in patch test reactions to structurally unrelated chemical irritants.
Topics: Anthralin; Benzalkonium Compounds; Cell Count; Cell Division; Croton Oil; Dermatitis, Contact; Fatty | 1993 |
The influence of topical dermatological treatment modalities on epidermal Langerhans cells and contact sensitization in mice.
Topics: Adenosine Triphosphatases; Administration, Topical; Animals; Anthralin; Coal Tar; Dermatitis, Contac | 1992 |
The effect of indomethacin on anthralin inflammation.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anthralin; Dermatitis, Contact; Edema; Erythema; F | 1992 |
Dithranol (anthralin)-induced skin irritation in C57BL/6, NMRI and SENCAR mice.
Topics: Animals; Anthralin; Dermatitis, Contact; Dose-Response Relationship, Drug; Edema; Female; Hyperplasi | 1991 |
Local- and systemic-mediated suppression of contact hypersensitivity in mice by several structurally unrelated classes of tumor promoters.
Topics: Administration, Topical; Alkanes; Alkynes; Animals; Anthralin; Antibody Formation; Benzoyl Peroxide; | 1991 |
'Irritants' increase the response to an allergen in allergic contact dermatitis.
Topics: Allergens; Anthralin; Dermatitis, Contact; Dose-Response Relationship, Drug; Drug Synergism; Humans; | 1991 |
Studies on the contact sensitizing activity of dithranol (anthralin) and 10-butyryl dithranol (butantrone).
Topics: Animals; Anthralin; Dermatitis, Contact; Disease Models, Animal; Dose-Response Relationship, Immunol | 1990 |
[Effect of cignolin and infrared irradiation on the patch test and lymphocyte transformation test].
Topics: Anthralin; Dermatitis, Contact; Humans; Infrared Rays; Lymphocyte Activation; Nickel; Patch Tests; P | 1990 |
Effect of BN 52021, a platelet activating factor antagonist, on dithranol-induced inflammation.
Topics: Adult; Anthralin; Capillary Resistance; Dermatitis, Contact; Diterpenes; Female; Ginkgolides; Humans | 1990 |
Structural determinants of the response of the skin to chemical irritants.
Topics: Adult; Ammonium Hydroxide; Anthralin; Dermatitis, Contact; Epidermis; Female; Humans; Hydroxides; Ma | 1988 |
Phenotypic characterization of the early cellular responses in allergic and irritant contact dermatitis.
Topics: Adult; Aged; Anthralin; Cell Count; Dermatitis, Contact; Epidermis; Female; Humans; Immunoenzyme Tec | 1986 |
In vitro and in vivo antiinflammatory activities of C10 substituted anthralin derivatives.
Topics: Animals; Anthralin; Anti-Inflammatory Agents, Non-Steroidal; Chemotaxis, Leukocyte; Dermatitis, Cont | 1987 |
Site variation in anthralin inflammation on forearm skin.
Topics: Adolescent; Adult; Aged; Anthracenes; Anthralin; Dermatitis, Contact; Female; Forearm; Humans; Male; | 1986 |
Irritant potential of dithranol.
Topics: Anthralin; Blister; Dermatitis, Contact; Dose-Response Relationship, Drug; Drug Incompatibility; Ery | 1986 |
Comparison of ultrasound and caliper measurements of normal and inflamed skin thickness.
Topics: Anthralin; Dermatitis, Contact; Humans; Skin; Skinfold Thickness; Ultrasonography | 1985 |
Mechanism of anthralin inflammation. I. Dissociation of response to clobetasol and indomethacin.
Topics: Adult; Aged; Anthracenes; Anthralin; Betamethasone; Clobetasol; Dermatitis, Contact; Edema; Erythema | 1985 |
Mechanism of anthralin inflammation. 2. Effect of pretreatment with glucocorticoids, anthralin and removal of stratum corneum.
Topics: Administration, Topical; Adult; Aged; Anthracenes; Anthralin; Anti-Inflammatory Agents; Betamethason | 1985 |